Eloraa Parenterals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Eloraa Parenterals
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Jain, Amit Gupta, Janpreet Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33201PB2022PTC057467
- Company No.
057467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eloraa Parenterals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Jain  | Director | 17-Dec-2022 | Current |
| Amit Gupta | Director | 17-Dec-2022 | Current |
| Janpreet Singh | Director | 17-Dec-2022 | Current |
| Manul Jain | Director | 17-Dec-2022 | Current |
| Abhay Jain | Director | 17-Dec-2022 | Current |
Financial Performance of Eloraa Parenterals.
Enhance accessibility to Eloraa Parenterals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eloraa Parenterals?
Unlock access to Eloraa Parenterals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cascade Buildtech Private LimitedActive 5 years 11 monthsAmit Gupta and Janpreet Singh are mutual person
Zeta Life Sciences Private LimitedActive 19 years 8 monthsRavi Jain and Abhay Jain are mutual person
- Evermark Developers And Promoters Private LimitedActive 4 years 2 months
Ravi Jain, Amit Gupta and 2 more are mutual person
- The Panipat Woollen And General Mills Co. LimitedActive 77 years 11 months
Amit Gupta and Janpreet Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eloraa Parenterals?
Eloraa Parenterals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eloraa Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eloraa Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.